Sienna Senior Living Inc.

OTCPK:LWSC.F Stock Report

Market Cap: US$899.3m

Sienna Senior Living Valuation

Is LWSC.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LWSC.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LWSC.F ($11.04) is trading above our estimate of fair value ($0.33)

Significantly Below Fair Value: LWSC.F is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LWSC.F?

Key metric: As LWSC.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LWSC.F. This is calculated by dividing LWSC.F's market cap by their current earnings.
What is LWSC.F's PE Ratio?
PE Ratio41.8x
EarningsCA$30.98m
Market CapCA$1.29b

Price to Earnings Ratio vs Peers

How does LWSC.F's PE Ratio compare to its peers?

The above table shows the PE ratio for LWSC.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average39.8x
USPH U.S. Physical Therapy
97.3x30.8%US$1.4b
NHC National HealthCare
13.6xn/aUS$1.7b
ARDT Ardent Health Partners
26.2x38.8%US$2.4b
PACS PACS Group
21.9x47.6%US$2.0b
LWSC.F Sienna Senior Living
41.8xn/aUS$1.3b

Price-To-Earnings vs Peers: LWSC.F is expensive based on its Price-To-Earnings Ratio (41.8x) compared to the peer average (40.1x).

Price to Earnings Ratio vs Industry

How does LWSC.F's PE Ratio compare vs other companies in the US Healthcare Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
THC Tenet Healthcare
3.9x-39.2%US$12.17b
NEUE NeueHealth
2.2xn/aUS$60.00m
IDXG Interpace Biosciences
2.4xn/aUS$12.76m
FZMD Fuse Medical
2.2xn/aUS$8.67m
LWSC.F 41.8xIndustry Avg. 21.9xNo. of Companies10PE01632486480+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LWSC.F is expensive based on its Price-To-Earnings Ratio (41.8x) compared to the US Healthcare industry average (22x).

Price to Earnings Ratio vs Fair Ratio

What is LWSC.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LWSC.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio41.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate LWSC.F's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LWSC.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$13.29
0%
3.8%US$14.04US$12.63n/a8
Dec ’25US$12.05
US$13.51
+12.1%
3.8%US$14.27US$12.84n/a8
Nov ’25US$12.53
US$13.05
+4.1%
6.6%US$14.40US$11.88n/a8
Oct ’25US$12.43
US$12.77
+2.7%
2.6%US$13.35US$12.24n/a7
Sep ’25US$11.31
US$12.77
+12.9%
2.6%US$13.35US$12.24n/a7
Aug ’25US$11.23
US$11.92
+6.2%
2.5%US$12.34US$11.61n/a7
Jul ’25US$9.93
US$12.00
+20.9%
2.3%US$12.49US$11.76n/a6
Jun ’25US$10.45
US$12.00
+14.9%
2.3%US$12.49US$11.76n/a6
May ’25US$9.76
US$10.60
+8.6%
4.0%US$11.33US$10.24n/a6
Apr ’25US$9.67
US$10.51
+8.7%
2.8%US$11.02US$10.29n/a5
Mar ’25US$9.80
US$10.51
+7.3%
1.7%US$10.74US$10.37n/a5
Feb ’25US$8.93
US$10.00
+12.0%
4.1%US$10.50US$9.37n/a6
Jan ’25US$8.64
US$10.00
+15.8%
4.1%US$10.50US$9.37n/a6
Dec ’24US$8.10
US$9.59
+18.4%
3.6%US$10.20US$9.11US$12.056
Nov ’24US$7.36
US$9.82
+33.4%
3.3%US$10.12US$9.40US$12.536
Oct ’24US$8.01
US$10.16
+26.8%
2.7%US$10.37US$9.63US$12.437
Sep ’24US$8.71
US$10.16
+16.7%
2.7%US$10.37US$9.63US$11.317
Aug ’24US$8.69
US$10.18
+17.1%
4.2%US$10.61US$9.48US$11.237
Jul ’24US$8.67
US$10.04
+15.8%
5.1%US$11.03US$9.56US$9.937
Jun ’24US$8.36
US$10.04
+20.0%
5.1%US$11.03US$9.56US$10.457
May ’24US$8.09
US$10.04
+24.1%
5.1%US$11.03US$9.56US$9.767
Apr ’24US$7.81
US$10.04
+28.5%
5.1%US$11.03US$9.56US$9.677
Mar ’24US$8.73
US$10.16
+16.3%
6.1%US$11.05US$9.58US$9.807
Feb ’24US$9.00
US$10.77
+19.7%
5.0%US$11.95US$10.45US$8.937
Jan ’24n/a
US$10.78
0%
4.9%US$11.89US$10.41US$8.648
Dec ’23US$8.58
US$10.78
+25.6%
4.9%US$11.89US$10.41US$8.108

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 03:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sienna Senior Living Inc. is covered by 20 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Clarence PowellBMO Capital Markets Equity Research
Pauline AlimchandaniBMO Capital Markets Equity Research
Brendon AbramsCanaccord Genuity